FDA Inspection
Peyman Saadat MD, Inc.Peyman Saadat MD, Inc. – FDA Inspection, Feb 20, 2024
Record Details
This FDA Inspection record concerns Peyman Saadat MD, Inc., with an inspection on February 20, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e226d855-6e16-4b64-9d28-5ef11a67542a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1231316
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 1271.265(c)(2)Improperly released for distribution
- 21 CFR 1271.55(b)(1)Statement re: certified testing lab
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Peyman Saadat MD, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 21, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 29, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| August 16, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 23, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Peyman Saadat MD, Inc.
- FDA Inspection 1045088 - 2018-03-21
- FDA Inspection 938669 - 2015-07-29
- FDA Inspection 796642 - 2012-08-16
- FDA Inspection 731983 - 2011-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.